Doximity, Inc.
DOCS · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $570 | $475 | $419 | $344 |
| % Growth | 20% | 13.5% | 22% | – |
| Cost of Goods Sold | $56 | $51 | $53 | $40 |
| Gross Profit | $515 | $425 | $366 | $304 |
| % Margin | 90.2% | 89.3% | 87.2% | 88.4% |
| R&D Expenses | $93 | $82 | $80 | $62 |
| G&A Expenses | $46 | $38 | $37 | $36 |
| SG&A Expenses | $191 | $171 | $160 | $128 |
| Sales & Mktg Exp. | $146 | $133 | $124 | $92 |
| Other Operating Expenses | $2 | $8 | $0 | $0 |
| Operating Expenses | $287 | $261 | $240 | $190 |
| Operating Income | $228 | $164 | $125 | $114 |
| % Margin | 39.9% | 34.5% | 29.9% | 33% |
| Other Income/Exp. Net | $36 | $21 | $8 | $0 |
| Pre-Tax Income | $264 | $185 | $133 | $114 |
| Tax Expense | $40 | $38 | $20 | -$41 |
| Net Income | $223 | $148 | $113 | $155 |
| % Margin | 39.1% | 31% | 26.9% | 45.1% |
| EPS | 1.19 | 0.78 | 0.58 | 0.81 |
| % Growth | 52.6% | 34.5% | -28.4% | – |
| EPS Diluted | 1.11 | 0.72 | 0.53 | 0.7 |
| Weighted Avg Shares Out | 187 | 190 | 193 | 163 |
| Weighted Avg Shares Out Dil | 201 | 206 | 213 | 191 |
| Supplemental Information | – | – | – | – |
| Interest Income | $36 | $22 | $9 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $11 | $10 | $10 | $5 |
| EBITDA | $241 | $182 | $135 | $119 |
| % Margin | 42.2% | 38.3% | 32.3% | 34.5% |